Medtronic (MDT) Earnings Analysis

Medtronic (MDT) next reports earnings on 2026-09-01, consensus EPS 1.39 USD. Last quarter (2026-06-03) it beat with EPS 1.55 USD vs 1.54 USD est (+0.6%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 21.84.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MDT next report earnings?

Next earnings date2026-09-01
Consensus EPS estimate1.39 USD
Revenue estimate9.55B

MDT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-06-031.55 USD1.54 USD+0.6%Beat
2026-02-171.36 USD1.34 USD+1.5%Beat
2025-11-181.36 USD1.31 USD+3.8%Beat
2025-08-191.26 USD1.23 USD+2.4%Beat
2025-05-211.62 USD1.58 USD+2.5%Beat
2025-02-181.39 USD1.36 USD+2.2%Beat
2024-11-191.26 USD1.25 USD+0.8%Beat
2024-08-201.23 USD1.2 USD+2.5%Beat

Beat rate: 8/8 (100%) over reported quarters with consensus data.

MDT valuation and analyst view

Trailing P/E21.84
Trailing EPS3.745 USD
Price / book2.12
Dividend yield3.48%
Market cap104.77B
Analyst consensusBuy (30 buy / 21 hold / 0 sell)
Avg price target90.33 USD

Related research pages

Frequently asked questions

When is Medtronic (MDT)'s next earnings date?

Medtronic is next scheduled to report on 2026-09-01, with a consensus EPS estimate of 1.39 USD and revenue estimate of 9.55B.

Did MDT beat earnings last quarter?

In its 2026-06-03 report, MDT posted EPS of 1.55 USD versus a 1.54 USD estimate — a beat of 0.6%.

What is MDT's earnings track record?

Over the last 8 reported quarters with consensus data, MDT beat estimates 8 times (100%).

What is MDT's current P/E ratio and EPS?

MDT trades at a trailing P/E of 21.84 on trailing EPS of 3.7447339678577003 USD.

What do analysts rate MDT?

Analyst consensus is "Buy" across 51 ratings (1 strong buy, 29 buy, 21 hold, 0 sell, 0 strong sell). Average 12-month price target: 90.33 USD.